National

SC directs States, UTs to furnish info on existing schemes for welfare of elderly

SC

New Delhi: The Supreme Court directed all the States governments and Union Territories (UTs) to furnish information on the existing schemes operating there with respect to the welfare of the elderly people.

A bench of Justices Aniruddha Bose and Sudhanshu Dhulia directed the States and UTs to furnish the details regarding pensions for the elderly, old age homes in each district and the level of geriatric care provided to them. โ€œLet the respective States and Union Territories furnish the information on their existing schemes on the aforesaid three heads to the advocate-on-record of the Union of India. After collecting information from all the respective States and the Union Territories within a period of two months. A revised status report shall be filed one month thereafter by the Union of India,โ€ the apex court stated in its order.
It directed that the revised report of the States shall also disclose the present status as regards the implementation of the Maintenance and Welfare of Parents and Senior Citizens Act.

โ€œLet copies of this order be sent by the Registry to the Chief Secretary of each State and the Union Territories for onward compliance of the directions contained in this order,โ€ the court ordered while posting the matter for hearing in January 2023.

Also Read: CDSCO Takes Up Urgent Investigation On WHOโ€™s complaint for India-Made Cough Syrups

The order of the top court came on a PIL filed by former Union Law Minister and senior advocate Ashwani Kumar regarding the enforcement of the rights of elderly people.

The plea sought direction for the adequate number of old-age homes across the country and the maintenance and operation of such homes with adequate standards.

Kumar had also sought direction from the top court arguing that there should be nationwide uniformity in the pension for elderly people.

(Except for the headline, this story has not been edited by HW News staff and is published from a syndicated feed).

Dear Readers,
As an independent media platform, we do not take advertisements from governments and corporate houses. It is you, our readers, who have supported us on our journey to do honest and unbiased journalism. Please contribute, so that we can continue to do the same in future.
Some error occurred

Related posts

International

CDSCO Takes Up Urgent Investigation On WHOโ€™s complaint for India-Made Cough Syrups

ANI
WHO

According to the sources, โ€œWHO on September 29, 2022, informed DCGI, the National Drug Regulator of India, that it is currently providing technical assistance and advice to the Gambia, where children were suspected to have died where a significant contributing factor, is suspected to be the use of medicines which may have been contaminated with Diethylene glycol or Ethylene glycol (this has been confirmed in some of the samples by further analysis conducted by WHO).โ€\The Central Drugs Standard Control Organisation(CDSCO) took up the matter immediately and further investigation was launched, โ€œCDSCO while responding to WHO within an hour and a half, took up the matter immediately thereafter with the concerned State Regulatory Authority, under whose jurisdiction the drug manufacturing unit is located.

New Delhi: After the World Health Organization (WHO) issued an alert on four India-made cough and cold syrups used for paediatric groups, the Central Drugs Standard Control Organisation (CDSCO) has taken up an urgent investigation in this regard.

โ€œUrgent investigation in the matter has been already taken up by CDSCO with the State Regulatory Authorities immediately after receiving communication from WHO based on the available information. While all required steps will be taken in the matter, as a robust National Regulatory Authority, WHO has been requested to share at the earliest with CDSCO the report on the establishment of causal relation to death with the medical products in question, photographs of Labels/ products etc. which is awaited,โ€ Sources told ANI. WHO on Wednesday issued an alert over four India-made cough and cold syrups which are made by Maiden Pharmaceuticals in India. WHO has also notified that the same cough and cold syrups could be linked to the deaths of 66 children in The Gambia.

According to the sources, โ€œWHO on September 29, 2022, informed DCGI, the National Drug Regulator of India, that it is currently providing technical assistance and advice to the Gambia, where children were suspected to have died where a significant contributing factor, is suspected to be the use of medicines which may have been contaminated with Diethylene glycol or Ethylene glycol (this has been confirmed in some of the samples by further analysis conducted by WHO).โ€\The Central Drugs Standard Control Organisation(CDSCO) took up the matter immediately and further investigation was launched, โ€œCDSCO while responding to WHO within an hour and a half, took up the matter immediately thereafter with the concerned State Regulatory Authority, under whose jurisdiction the drug manufacturing unit is located.

Further, a detailed investigation was launched to ascertain the facts/ details in the matter in collaboration with State Drugs Controller, Haryana (the concerned State Drug Control Authority), said sources.

Also Read:No Drugs, Just Baking Soda: Mumbai Court Discharges Man In Narcotics Case After 6 Years

From the preliminary enquiry, it has been made out that Maiden Pharmaceutical Limited, Sonipat, Haryana is a manufacturer licensed by the State Drug Controller for the products under reference, and holds manufacturing permission for these products. The company has manufactured and exported these products only to The Gambia so far.

โ€œIt is a practice that the importing country tests these products on quality parameters, and satisfies itself as to the quality of the products before their release for usage in the country,โ€ said a source and explained the quality parameter needs to be followed by the country that imports these products.

โ€œAs per the tentative results received by WHO out of the 23 samples tested, four samples have been found to contain Diethylene Glycol/ Ethylene Glycol as indicated. It has also been informed by WHO that the certificate of analysis will be made available to WHO in near future and WHO will share it with India. At the same time, the exact one-to-one causal relation of death has not yet been provided by WHO, nor have the details of Labels/ products been shared by WHO with CDSCO enabling it to confirm the identity/ source of the manufacturing of the products,โ€ they said.

(Except for the headline, this story has not been edited by HW News staff and is published from a syndicated feed).

Related posts

News Hub